Viva Biotech Holdings Management
Management criteria checks 4/4
Viva Biotech Holdings' CEO is Chen Cheney Mao, appointed in Jul 2018, has a tenure of 6.33 years. total yearly compensation is CN¥2.39M, comprised of 60.8% salary and 39.2% bonuses, including company stock and options. directly owns 15.81% of the company’s shares, worth $38.35M. The average tenure of the management team and the board of directors is 3.6 years and 5.6 years respectively.
Key information
Chen Cheney Mao
Chief executive officer
CN¥2.4m
Total compensation
CEO salary percentage | 60.8% |
CEO tenure | 6.3yrs |
CEO ownership | 15.8% |
Management average tenure | 3.6yrs |
Board average tenure | 5.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -CN¥318k |
Mar 31 2024 | n/a | n/a | -CN¥58m |
Dec 31 2023 | CN¥2m | CN¥1m | -CN¥116m |
Sep 30 2023 | n/a | n/a | -CN¥276m |
Jun 30 2023 | n/a | n/a | -CN¥436m |
Mar 31 2023 | n/a | n/a | -CN¥482m |
Dec 31 2022 | CN¥3m | CN¥1m | -CN¥528m |
Sep 30 2022 | n/a | n/a | -CN¥209m |
Jun 30 2022 | n/a | n/a | CN¥111m |
Mar 31 2022 | n/a | n/a | CN¥199m |
Dec 31 2021 | CN¥2m | CN¥1m | CN¥288m |
Sep 30 2021 | n/a | n/a | CN¥258m |
Jun 30 2021 | n/a | n/a | CN¥228m |
Mar 31 2021 | n/a | n/a | -CN¥79m |
Dec 31 2020 | CN¥1m | CN¥957k | -CN¥387m |
Sep 30 2020 | n/a | n/a | -CN¥349m |
Jun 30 2020 | n/a | n/a | -CN¥311m |
Mar 31 2020 | n/a | n/a | -CN¥23m |
Dec 31 2019 | CN¥1m | CN¥954k | CN¥266m |
Compensation vs Market: Chen Cheney's total compensation ($USD330.77K) is below average for companies of similar size in the US market ($USD1.46M).
Compensation vs Earnings: Chen Cheney's compensation has been consistent with company performance over the past year.
CEO
Chen Cheney Mao (62 yo)
6.3yrs
Tenure
CN¥2,394,000
Compensation
Dr. Chen Cheney Mao, Ph D has been Chairman of Viva Biotech Holdings since July 03, 2018 and served as Chief Executive Officer of Viva Biotech Holdings since July 03, 2018 until December 1, 2023. He Founde...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 6.3yrs | CN¥2.39m | 15.81% $ 38.3m | |
Executive VP & Executive Director | 6.3yrs | CN¥2.68m | 0.81% $ 2.0m | |
Executive Director | less than a year | CN¥3.68m | 0.70% $ 1.7m | |
Chief Financial Officer | less than a year | no data | no data | |
Chief Technology Officer | 5.3yrs | no data | no data | |
Chief Scientific Officer | 6.3yrs | no data | no data | |
Chief Innovation Officer & Head of Viva BioInnovator | no data | no data | no data | |
Senior Vice President | no data | no data | no data | |
Senior VP & President of Shanghai Langhua Pharmaceutical | no data | no data | no data | |
CBO & EVP of Viva Biotech (Shanghai) | no data | no data | no data | |
Senior Vice President | 2yrs | no data | no data | |
CEO of Viva Biotech (Shanghai) Ltd. | less than a year | no data | no data |
3.6yrs
Average Tenure
61.5yo
Average Age
Experienced Management: VBIZ.F's management team is considered experienced (3.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 6.3yrs | CN¥2.39m | 15.81% $ 38.3m | |
Executive VP & Executive Director | 15.2yrs | CN¥2.68m | 0.81% $ 2.0m | |
Executive Director | 6.3yrs | CN¥3.68m | 0.70% $ 1.7m | |
Independent Non-Executive Director | 5.6yrs | CN¥225.00k | no data | |
Independent Non-Executive Director | 5.6yrs | CN¥225.00k | no data | |
Independent Non-Executive Director | 5.6yrs | CN¥225.00k | no data | |
Non-Executive Director | 2yrs | CN¥225.00k | no data | |
Non-Executive Director | less than a year | no data | 4.01% $ 9.7m |
5.6yrs
Average Tenure
61yo
Average Age
Experienced Board: VBIZ.F's board of directors are considered experienced (5.6 years average tenure).